Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Docetaxel and Cisplatin in Advanced NPC
NCT00436293Phase 2Completed
- Sponsor
- Sanofi
- Start
- Dec 2002
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in nasopharyngeal carcinoma (NPC), sponsored by Sanofi. Started Dec 2002; status: completed.
02
Drugs
docetaxel
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT00436293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00436293.